Ireland suspends Astrazeneca COVID-19 vaccine

Ireland temporarily suspended AstraZeneca’s COVID-19 vaccine “out of an abundance of caution” on Sunday, citing reports from the Norwegian Medicines Agency regarding a cluster of serious blood clotting in some recipients there.

Ireland temporarily suspended AstraZeneca’s COVID-19 vaccine “out of an abundance of caution” on Sunday, citing reports from the Norwegian Medicines Agency regarding a cluster of serious blood clotting in some recipients there. Three health workers in Norway who had recently received the AstraZeneca COVID-19 vaccine were being treated in hospital for bleeding, blood clots and a low count of blood platelets, its health authorities said on Saturday. Ireland’s National Immunisation Advisory Committee (NIAC) recommended the temporary deferral pending the receipt of more information from European regulators in the coming days.